[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360131-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-360131-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","immunologic-combinations-in-multiple-myeloma-review-synergistic-stimulation-with-t-cells-and-nk-cells","Immunologic Combinations in Multiple Myeloma - Review - Synergistic Stimulation with T cells and NK cells","","Multiple myeloma (MM) features malignant proliferation of bone marrow plasma cells, with the tumor microenvironment (TME) acting as a central driver of disease development and progression. T cells, NK cells, and NKT cells represent key anti-MM immune populations in the bone marrow microenvironment (BMME). Despite direct contact and cytokine-mediated tumor control, MM suppresses T-cell and NK-cell functions, contributing to inadequate anti-tumor immunity. This review summarizes mechanisms of T-cell and NK-cell inhibition and highlights emerging dual-target immunotherapies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/immunologic-combinations-in-multiple-myeloma-review-synergistic-stimulation-with-t-cells-and-nk-cells/360131/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/immunologic-combinations-in-multiple-myeloma-review-synergistic-stimulation-with-t-cells-and-nk-cells/360131.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why do T cells and NK cells become insufficient against multiple myeloma?","Question",{"text":63,"@type":64},"Multiple myeloma suppresses T cells and NK cells through mechanisms that impair their function, including inhibitory cytokine effects, altered receptor signaling, up-regulated inhibitory receptors, and tumor microenvironment hypoxia.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do T cells and NK cells recognize tumor cells differently?",{"text":68,"@type":64},"T cells recognize tumor-associated peptides presented by MHC class I via the T cell receptor (TCR), while NK cells detect non-MHC-I-like tumor antigens using activating and inhibitory surface receptors.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic direction does the review emphasize for MM treatment?",{"text":72,"@type":64},"The review focuses on immunotherapies that counteract immune suppression by simultaneously reactivating T cells and NK cells, aiming to synergistically strengthen anti-myeloma immunity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},360131,1790193573,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Ivyspring  \nInternational Publisher  \nInternationalJournal of Biological Sciences  \n2026; 22(9): 4477-4495. doi: 10.7150/ijbs.127871  \nReview  \nImmunologic Combinations in Multiple Myeloma: Synergistic Stimulation with T cells and NK cells  \nZhaoYun Liu\\#􀀍, Jiao Lai\\#, Chun Yang, Hui Liu, Kai Ding, Jia Song, Rong Fu􀀍  \nDepartment of Hematology, Tianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300052, China, Tianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin Institute of Hematology, State Key Laboratory of Experimental Hematology.  \n\\# ZhaoYun Liu and Jiao Lai are co-first authors.  \n􀀍 Corresponding authors: Zhaoyun Liu, MD. E-mail: [liuzhaoyun114@163.com](liuzhaoyun114@163.com); Rong Fu, Professor. E-mail: [furong8369@tmu.edu.cn](furong8369@tmu.edu.cn).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.11.04; Accepted: 2026.03.02; Published: 2026.04.16  \nAbstract  \nBone marrow plasma cells proliferate malignantly in multiple myeloma (MM), a hematological cancer. MM is now the second most common hematologic illness, followed by non-Hodgkin’s lymphoma. The tumor microenvironment (TME) is a crucial factor in MM development. T cells, natural killer (NK) cells, and natural killer T (NKT) cells are the key anti-MM immune cells in the bone marrow microenvironment (BMME). By direct contact or cytokine production, these cells prevent MM cells from proliferation and survival. However, a major factor contributing to the insufficiency of anti-tumor immune responses is the inhibition of T cells and NK cells functions. We aimed to summarize the mechanisms of T cells and NK cells suppression in MM and discuss emerging immunotherapies that target both cell types  \nKeywords: Multiple myeloma, Immunotherapy, Cancer Vaccines, bone marrow microenvironment  \nIntroduction  \nMM is a malignancy originating from bone marrow plasma cells, and the onset and progression of MM are closely related to the BMME [1] . The development of immunosuppressive cells, malfunctioning of effector cells, and inhibition of anti-tumor immunity through the production of cytokines and metabolites gradually disrupt the immune milieu, resulting in carcinogenesis, and progression [2, 3] . The milieu surrounding myeloid-derived suppressor cells (MDSCs) in the bone marrow is constituted of complex interactions between extracellular matrix (ECM) proteins and a wide range of cellular constituents, such as endothelial cells, stromal cells, osteoblasts, and osteoclasts, as well as multiple immune cells, such as T cells, NK cells, monocytes, and MDSCs. These cells work together to promote the development of MDSCs [4] . Immune cells, particularly T cells and NK cells, are essential to coordinate anti-tumor immune responses within the BMME [5] . However, the tumor  \nmicroenvironment in MM significantly inhibits the function of these immune cells [6] . Through a number of mechanisms, including cytokine inhibitory effects, inhibition of activating receptors, up-regulation of inhibitory receptors, and hypoxia in the tumor microenvironment, the MM microenvironment suppresses the ability of NK and T cells, allowing tumor progression and immune escape for MM cells [7] . Researchers have devised numerous novel therapeutic strategies to counteract immunosuppression with the intention of revitalizing the immune defenses against tumors by concurrently activating T cells and NK cells [8] . We aimed to review the mechanisms underlying the immunosuppression of T cells and NK cells, explore the common factors contributing to the suppressed state of these immune cells, discuss approaches for dual immune activation, and highlight innovative the","cbCaimulRiUvaQYD","https://ap.wps.com/l/cbCaimulRiUvaQYD","pdf",3775263,"English","# Introduction\n## Suppressed immune function of T cells and NK cells\n## Differences between T cells and NK cells","[{\"question\":\"Why do T cells and NK cells become insufficient against multiple myeloma?\",\"answer\":\"Multiple myeloma suppresses T cells and NK cells through mechanisms that impair their function, including inhibitory cytokine effects, altered receptor signaling, up-regulated inhibitory receptors, and tumor microenvironment hypoxia.\"},{\"question\":\"How do T cells and NK cells recognize tumor cells differently?\",\"answer\":\"T cells recognize tumor-associated peptides presented by MHC class I via the T cell receptor (TCR), while NK cells detect non-MHC-I-like tumor antigens using activating and inhibitory surface receptors.\"},{\"question\":\"What therapeutic direction does the review emphasize for MM treatment?\",\"answer\":\"The review focuses on immunotherapies that counteract immune suppression by simultaneously reactivating T cells and NK cells, aiming to synergistically strengthen anti-myeloma immunity.\"}]","Immunologic Combinations in Multiple Myeloma - Review - Synergistic Stimulation with T cells and NK cells | PDF",1790138839,48,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05ee70ed74081e804a9d63a153abac14.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/584c3f79e51ff42f9d655c164440a75b.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1a010c4bbe98b7a47057cf821d66653.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44563939ea53c0fb52e9ce5303b8d1a6.webp",980,1268]